Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Bharadwaj, Uddalak; Kasembeli, Moses M; Robinson, Prema; Tweardy, David J

Bharadwaj, Uddalak; Kasembeli, Moses M; Robinson, Prema; Tweardy, David J.

Affiliation

Bharadwaj U; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine (U.B., M.M.K., P.R., D.J.T.), and Department of Molecular and Cellular Oncology (D.J.T.), University of Texas, MD Anderson Cancer Center, Houston, Texas.
Kasembeli MM; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine (U.B., M.M.K., P.R., D.J.T.), and Department of Molecular and Cellular Oncology (D.J.T.), University of Texas, MD Anderson Cancer Center, Houston, Texas.
Robinson P; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine (U.B., M.M.K., P.R., D.J.T.), and Department of Molecular and Cellular Oncology (D.J.T.), University of Texas, MD Anderson Cancer Center, Houston, Texas.
Tweardy DJ; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine (U.B., M.M.K., P.R., D.J.T.), and Department of Molecular and Cellular Oncology (D.J.T.), University of Texas, MD Anderson Cancer Center, Houston, Texas djtweardy@mdanderson.org.

Pharmacol Rev ; 72(2): 486-526, 2020 04.

Article in En | MEDLINE | ID: mdl-32198236

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibrosis / STAT3 Transcription Factor / Janus Kinases / Inflammation / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Pharmacol Rev Year: 2020 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google